Novartis AG is buying US biotechnology company, The Medicines Co, for about $9.7 billion, the Swiss drugmaker said on Sunday, as it seeks to expand its portfolio of medicines against cardiovascular disease.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2XGdeFG
